Telomere recombination and alternative telomere lengthening mechanisms

Frontiers in Bioscience

Volumn 18, Issue 1, 2013, Pages 1-20

  Draskovic, Irena ^a   Vallejo, Arturo Londono ^a  

^a CNRS   (France)

Author keywords

ALT; Alternative Lengthening of telomeres; APB; Chromatin; DNA methylation; Histone modifications; Review; Shelterin

Indexed keywords

BLOOM SYNDROME HELICASE; EXODEOXYRIBONUCLEASE; HELICASE; RECQ HELICASE; REGULATOR OF TELOMERE LENGTH PROTEIN, MOUSE; SHELTERIN, HUMAN; TELOMERASE; TELOMERE BINDING PROTEIN; WRN PROTEIN, HUMAN;

ANIMAL; DNA METHYLATION; GENETIC RECOMBINATION; GENOMIC INSTABILITY; HETEROCHROMATIN; HUMAN; METABOLISM; MOUSE; PHYSIOLOGY; REVIEW; TELOMERE; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING;

ANIMALS; DNA HELICASES; DNA METHYLATION; EXODEOXYRIBONUCLEASES; GENOMIC INSTABILITY; HETEROCHROMATIN; HUMANS; MICE; RECOMBINATION, GENETIC; RECQ HELICASES; TELOMERASE; TELOMERE; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING; TELOMERE-BINDING PROTEINS;

MLCS; MLOWN;

EID: 84878810164     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/4084     Document Type: Review

References (137)

1. T. de Lange: Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev, 19(18), 2100- 10 (2005)
2. W. Palm and T. de Lange: How shelterin protects mammalian telomeres. Annu Rev Genet, 42, 301-34 (2008)
3. R. J. O'Sullivan and J. Karlseder: Telomeres: protecting chromosomes against genome instability. Nat Rev Mol Cell Biol, 11(3), 171-81 (2010)
4. Y. C. Lam, S. Akhter, P. Gu, J. Ye, A. Poulet, M. J. Giraud-Panis, S. M. Bailey, E. Gilson, R. J. Legerski and S. Chang: SNMIB/Apollo protects leading-strand telomeres against NHEJ-mediated repair. Embo J, 29(13), 2230-41 (2010)
5. P. Wu, M. van Overbeek, S. Rooney and T. de Lange: Apollo contributes to G overhang maintenance and protects leading-end telomeres. Mol Cell, 39(4), 606-17 (2010)
6. Y. Deng, X. Guo, D. O. Ferguson and S. Chang: Multiple roles for MRE11 at uncapped telomeres. Nature, 460(7257), 914-8 (2009)
7. L. Hayflick: The Limited in Vitro Lifetime of Human Diploid Cell Strains. Exp Cell Res, 37, 614-36 (1965)
8. C. B. Harley, A. B. Futcher and C. W. Greider: Telomeres shorten during ageing of human fibroblasts. Nature, 345(6274), 458-60 (1990)
9. U. M. Martens, E. A. Chavez, S. S. Poon, C. Schmoor and P. M. Lansdorp: Accumulation of short telomeres in human fibroblasts prior to replicative senescence. Exp Cell Res, 256(1), 291-9 (2000)
10. A. J. Lustig: Clues to catastrophic telomere loss in mammals from yeast telomere rapid deletion. Nat Rev Genet, 4(11), 916-23 (2003)
11. L. H. Bechard, N. Jamieson and M. J. McEachern: Recombination can cause telomere elongations as well as truncations deep within telomeres in wild-type Kluyveromyces lactis cells. Eukaryot Cell, 10(2), 226-36 (2011)
12. H. A. Pickett, A. J. Cesare, R. L. Johnston, A. A. Neumann and R. R. Reddel: Control of telomere length by a trimming mechanism that involves generation of t-circles. Embo J, 28(7), 799-809 (2009)
13. H. A. Pickett, J. D. Henson, A. Y. Au, A. A. Neumann and R. R. Reddel: Normal mammalian cells negatively regulate telomere length by telomere trimming. Hum Mol Genet, 20(23), 4684-92 (2011) doi:ddr402 [pii]
14. B. T. Letsolo, J. Rowson and D. M. Baird: Fusion of short telomeres in human cells is characterized by extensive deletion and microhomology, and can result in complex rearrangements. Nucleic Acids Res, 38(6), 1841-52 (2010)
15. R. Capper, B. Britt-Compton, M. Tankimanova, J. Rowson, B. Letsolo, S. Man, M. Haughton and D. M. Baird: The nature of telomere fusion and a definition of the critical telomere length in human cells. Genes Dev, 21(19), 2495-508 (2007)
16. D. Miller, G. E. Reynolds, R. Mejia, J. M. Stark and J. P. Murnane: Subtelomeric regions in mammalian cells are deficient in DNA double-strand break repair. DNA Repair (Amst), 10(5), 536-44 (2011)
17. J. P. Murnane: Telomere loss as a mechanism for chromosome instability in human cancer. Cancer Res, 70(11), 4255-9 (2010)
18. V. P. Schulz and V. A. Zakian: The saccharomyces PIF1 DNA helicase inhibits telomere elongation and de novo telomere formation. Cell, 76(1), 145-55 (1994)
19. U. Herbig, M. Ferreira, L. Condel, D. Carey and J. M. Sedivy: Cellular senescence in aging primates. Science, 311(5765), 1257 (2006)
20. H. C. Mefford, E. Linardopoulou, D. Coil, G. van den Engh and B. J. Trask: Comparative sequencing of a multicopy subtelomeric region containing olfactory receptor genes reveals multiple interactions between non-homologous chromosomes. Hum Mol Genet, 10(21), 2363-72. (2001)
21. R. Court, L. Chapman, L. Fairall and D. Rhodes: How the human telomeric proteins TRF1 and TRF2 recognize telomeric DNA: a view from high-resolution crystal structures. EMBO Rep, 6(1), 39-45 (2005)
22. T. Bilaud, C. Brun, K. Ancelin, C. E. Koering, T. Laroche and E. Gilson: Telomeric localization of TRF2, a novel human telobox protein. Nat Genet, 17(2), 236-9 (1997)
23. D. Broccoli, A. Smogorzewska, L. Chong and T. de Lange: Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nat Genet, 17(2), 231-5 (1997)
24. D. Loayza and T. De Lange: POT1 as a terminal transducer of TRF1 telomere length control. Nature, 423(6943), 1013-8 (2003)
25. S. Cacchione, M. A. Cerone and M. Savino: In vitro low propensity to form nucleosomes of four telomeric sequences. FEBS Lett, 400(1), 37-41 (1997)
26. J. D. Griffith, L. Comeau, S. Rosenfield, R. M. Stansel, A. Bianchi, H. Moss and T. de Lange: Mammalian telomeres end in a large duplex loop. Cell, 97(4), 503-14 (1999)
27. J. Griffith, A. Bianchi and T. de Lange: TRF1 promotes parallel pairing of telomeric tracts in vitro. J Mol Biol, 278(1), 79-88 (1998)
28. S. Amiard, M. Doudeau, S. Pinte, A. Poulet, C. Lenain, C. Faivre-Moskalenko, D. Angelov, N. Hug, A. Vindigni, P. Bouvet, J. Paoletti, E. Gilson and M. J. Giraud-Panis: A topological mechanism for TRF2-enhanced strand invasion. Nat Struct Mol Biol, 14(2), 147-54 (2007)
29. V. Viglasky, L. Bauer, K. Tluckova and P. Javorsky: Evaluation of human telomeric g-quadruplexes: the influence of overhanging sequences on quadruplex stability and folding. J Nucleic Acids, 2010, 8 (2010)
30. D. K. Singh, A. K. Ghosh, D. L. Croteau and V. A. Bohr: RecQ helicases in DNA double strand break repair and telomere maintenance. Mutat Res, In Press (2011)
31. T. George, Q. Wen, R. Griffiths, A. Ganesh, M. Meuth and C. M. Sanders: Human Pif1 helicase unwinds synthetic DNA structures resembling stalled DNA replication forks. Nucleic Acids Res, 37(19), 6491-502 (2009)
32. K. Paeschke, J. A. Capra and V. A. Zakian: DNA Replication through G-Quadruplex Motifs Is Promoted by the Saccharomyces cerevisiae Pif1 DNA Helicase. Cell, 145(5), 678-91 (2011)
33. H. Wang, G. J. Nora, H. Ghodke and P. L. Opresko: Single molecule studies of physiologically relevant telomeric tails reveal POT1 mechanism for promoting G-quadruplex unfolding. J Biol Chem, 286(9), 7479-89 (2011)
34. N. Arnoult, C. Saintome, I. Ourliac-Garnier, J. F. Riou and A. Londono-Vallejo: Human POT1 is required for efficient telomere C-rich strand replication in the absence of WRN. Genes Dev, 23(24), 2915-24 (2009)
35. P. Martinez and M. A. Blasco: Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins. Nat Rev Cancer, 11(3), 161-76 (2011)
36. J. P. Murnane, L. Sabatier, B. A. Marder and W. F. Morgan: Telomere dynamics in an immortal human cell line. Embo J, 13(20), 4953-62 (1994)
37. T. M. Bryan, A. Englezou, J. Gupta, S. Bacchetti and R. R. Reddel: Telomere elongation in immortal human cells without detectable telomerase activity. Embo J, 14(17), 4240-8 (1995)
38. M. A. Dunham, A. A. Neumann, C. L. Fasching and R. R. Reddel: Telomere maintenance by recombination in human cells. Nat Genet, 26(4), 447-50 (2000)
39. K. Lafferty-Whyte, C. J. Cairney, M. B. Will, N. Serakinci, M. G. Daidone, N. Zaffaroni, A. Bilsland and W. N. Keith: A gene expression signature classifying telomerase and ALT immortalization reveals an hTERT regulatory network and suggests a mesenchymal stem cell origin for ALT. Oncogene, 28(43), 3765-74 (2009)
40. C. J. Cairney, S. F. Hoare, M. G. Daidone, N. Zaffaroni and W. N. Keith: High level of telomerase RNA gene expression is associated with chromatin modification, the ALT phenotype and poor prognosis in liposarcoma. Br J Cancer, 98(8), 1467-74 (2008)
41. J. D. Henson, J. A. Hannay, S. W. McCarthy, J. A. Royds, T. R. Yeager, R. A. Robinson, S. B. Wharton, D. A. Jellinek, S. M. Arbuckle, J. Yoo, B. G. Robinson, D. L. Learoyd, P. D. Stalley, S. F. Bonar, D. Yu, R. E. Pollock and R. R. Reddel: A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas. Clin Cancer Res, 11(1), 217-25 (2005)
42. J. N. Jeyapalan, A. Mendez-Bermudez, N. Zaffaroni, Y. E. Dubrova and N. J. Royle: Evidence for alternative lengthening of telomeres in liposarcomas in the absence of ALT-associated PML bodies. Int J Cancer, 122(11), 2414-21 (2008)
43. L. Liu, S. M. Bailey, M. Okuka, P. Munoz, C. Li, L. Zhou, C. Wu, E. Czerwiec, L. Sandler, A. Seyfang, M. A. Blasco and D. L. Keefe: Telomere lengthening early in development. Nat Cell Biol, 9(12), 1436-41 (2007)
44. A. J. Cesare and R. R. Reddel: Telomere uncapping and alternative lengthening of telomeres. Mech Ageing Dev, 129(1-2), 99-108 (2008)
45. R. R. Reddel: Senescence: an antiviral defense that is tumor suppressive? Carcinogenesis, 31(1), 19-26 (2010)
46. A. J. Cesare and R. R. Reddel: Alternative lengthening of telomeres: models, mechanisms and implications. Nat Rev Genet, 11(5), 319-30 (2010)
47. A. J. Cesare and J. D. Griffith: Telomeric DNA in ALT cells is characterized by free telomeric circles and heterogeneous t-loops. Mol Cell Biol, 24(22), 9948-57 (2004)
48. J. D. Henson, Y. Cao, L. I. Huschtscha, A. C. Chang, A. Y. Au, H. A. Pickett and R. R. Reddel: DNA C-circles are specific and quantifiable markers of alternative-lengthening-of-telomeres activity. Nat Biotechnol, 27(12), 1181-5 (2009)
49. C. L. Fasching, A. A. Neumann, A. Muntoni, T. R. Yeager and R. R. Reddel: DNA damage induces alternative lengthening of telomeres (ALT) associated promyelocytic leukemia bodies that preferentially associate with linear telomeric DNA. Cancer Res, 67(15), 7072-7 (2007)
50. J. T. Holthausen, C. Wyman and R. Kanaar: Regulation of DNA strand exchange in homologous recombination. DNA Repair (Amst), 9(12), 1264-72 (2010)
51. I. Draskovic, N. Arnoult, V. Steiner, S. Bacchetti, P. Lomonte and A. Londono-Vallejo: Probing PML body function in ALT cells reveals spatiotemporal requirements for telomere recombination. Proc Natl Acad Sci U S A, 106(37), 15726-31 (2009)
52. J. A. Londono-Vallejo, H. Der-Sarkissian, L. Cazes, S. Bacchetti and R. R. Reddel: Alternative lengthening of telomeres is characterized by high rates of telomeric exchange. Cancer Res, 64(7), 2324-7 (2004)
53. S. Natarajan and M. J. McEachern: Recombinational telomere elongation promoted by DNA circles. Mol Cell Biol, 22(13), 4512-21 (2002)
54. G. Cimino-Reale, E. Pascale, E. Battiloro, G. Starace, R. Verna and E. D'Ambrosio: The length of telomeric G-rich strand 3′-overhang measured by oligonucleotide ligation assay. Nucleic Acids Res, 29(7), E35 (2001)
55. M. Tarsounas, P. Munoz, A. Claas, P. G. Smiraldo, D. L. Pittman, M. A. Blasco and S. C. West: Telomere maintenance requires the RAD51D recombination/repair protein. Cell, 117(3), 337-47 (2004)
56. T. Sugiyama and S. C. Kowalczykowski: Rad52 protein associates with replication protein A (RPA)-single-stranded DNA to accelerate Rad51-mediated displacement of RPA and presynaptic complex formation. J Biol Chem, 277(35), 31663-72 (2002)
57. R. L. Flynn, R. C. Centore, R. J. O'Sullivan, R. Rai, A. Tse, Z. Songyang, S. Chang, J. Karlseder and L. Zou: TERRA and hnRNPA1 orchestrate an RPA-to-POT1 switch on telomeric single-stranded DNA. Nature, 471(7339), 532-6 (2011)
58. M. S. Wold: Replication protein A: a heterotrimeric, single-stranded DNA-binding protein required for eukaryotic DNA metabolism. Annu Rev Biochem, 66, 61-92 (1997)
59. T. R. Salas, I. Petruseva, O. Lavrik, A. Bourdoncle, J. L. Mergny, A. Favre and C. Saintome: Human replication protein A unfolds telomeric G-quadruplexes. Nucleic Acids Res, 34(17), 4857-65 (2006)
60. J. R. Lydeard, S. Jain, M. Yamaguchi and J. E. Haber: Break-induced replication and telomerase-independent telomere maintenance require Pol32. Nature, 448(7155), 820-3 (2007)
61. J. R. Lydeard, Z. Lipkin-Moore, Y. J. Sheu, B. Stillman, P. M. Burgers and J. E. Haber: Break-induced replication requires all essential DNA replication factors except those specific for pre-RC assembly. Genes Dev, 24(11), 1133-44 (2010)
62. U. Rass, S. A. Compton, J. Matos, M. R. Singleton, S. C. Ip, M. G. Blanco, J. D. Griffith and S. C. West: Mechanism of Holliday junction resolution by the human GEN1 protein. Genes Dev, 24(14), 1559-69 (2010)
63. L. Wu and I. D. Hickson: The Bloom's syndrome helicase suppresses crossing over during homologous recombination. Nature, 426(6968), 870-4 (2003)
64. J. M. Svendsen and J. W. Harper: GEN1/Yen1 and the SLX4 complex: Solutions to the problem of Holliday junction resolution. Genes Dev, 24(6), 521-36 (2009)
65. C. K. Ho, G. Mazon, A. F. Lam and L. S. Symington: Mus81 and Yen1 promote reciprocal exchange during mitotic recombination to maintain genome integrity in budding yeast. Mol Cell, 40(6), 988-1000 (2010)
66. S. Zeng, T. Xiang, T. K. Pandita, I. Gonzalez-Suarez, S. Gonzalo, C. C. Harris and Q. Yang: Telomere recombination requires the MUS81 endonuclease. Nat Cell Biol, 11(5), 616-23 (2009)
67. R. M. McCarroll and W. L. Fangman: Time of replication of yeast centromeres and telomeres. Cell, 54(4), 505-13 (1988)
68. N. Arnoult, C. Schluth-Bolard, A. Letessier, I. Drascovic, R. Bouarich-Bourimi, J. Campisi, S. H. Kim, A. Boussouar, A. Ottaviani, F. Magdinier, E. Gilson and A. Londono-Vallejo: Replication timing of human telomeres is chromosome arm-specific, influenced by subtelomeric structures and connected to nuclear localization. PLoS Genet, 6(4), e1000920 (2010)
69. W. E. Wright, V. M. Tesmer, M. L. Liao and J. W. Shay: Normal human telomeres are not late replicating. Exp Cell Res, 251(2), 492-9 (1999)
70. K. G. Ten Hagen and S. N. Cohen: Timing of replication of beta satellite repeats of human chromosomes. Nucleic Acids Res, 21(9), 2139-42 (1993)
71. Y. Zou, A. Sfeir, S. M. Gryaznov, J. W. Shay and W. E. Wright: Does a sentinel or a subset of short telomeres determine replicative senescence? Mol Biol Cell, 15(8), 3709-18 (2004)
72. O. E. Bechter, J. W. Shay and W. E. Wright: The frequency of homologous recombination in human ALT cells. Cell Cycle, 3(5), 547-9 (2004)
73. T. R. Yeager, A. A. Neumann, A. Englezou, L. I. Huschtscha, J. R. Noble and R. R. Reddel: Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res, 59(17), 4175-9 (1999)
74. O. Bischof, S. H. Kim, J. Irving, S. Beresten, N. A. Ellis and J. Campisi: Regulation and localization of the Bloom syndrome protein in response to DNA damage. J Cell Biol, 153(2), 367-80 (2001)
75. D. B. Lombard and L. Guarente: Nijmegen breakage syndrome disease protein and MRE11 at PML nuclear bodies and meiotic telomeres. Cancer Res, 60(9), 2331-4 (2000)
76. J. J. Luciani, D. Depetris, Y. Usson, C. Metzler-Guillemain, C. Mignon-Ravix, M. J. Mitchell, A. Megarbane, P. Sarda, H. Sirma, A. Moncla, J. Feunteun and M. G. Mattei: PML nuclear bodies are highly organised DNA-protein structures with a function in heterochromatin remodelling at the G2 phase. J Cell Sci, 119(Pt 12), 2518-31 (2006)
77. W. Q. Jiang, Z. H. Zhong, J. D. Henson, A. A. Neumann, A. C. Chang and R. R. Reddel: Suppression of alternative lengthening of telomeres by Sp100-mediated sequestration of the MRE11/RAD50/NBS1 complex. Mol Cell Biol, 25(7), 2708-21 (2005)
78. Z. H. Zhong, W. Q. Jiang, A. J. Cesare, A. A. Neumann, R. Wadhwa and R. R. Reddel: Disruption of telomere maintenance by depletion of the MRE11/RAD50/NBS1 complex in cells that use alternative lengthening of telomeres. J Biol Chem, 282(40), 29314-22 (2007)
79. A. J. Cesare, Z. Kaul, S. B. Cohen, C. E. Napier, H. A. Pickett, A. A. Neumann and R. R. Reddel: Spontaneous occurrence of telomeric DNA damage response in the absence of chromosome fusions. Nat Struct Mol Biol, 16(12), 1244-51 (2009)
80. R. Bernardi and P. P. Pandolfi: Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat Rev Mol Cell Biol, 8(12), 1006-16 (2007)
81. R. D. Everett, J. Murray, A. Orr and C. M. Preston: Herpes simplex virus type 1 genomes are associated with ND10 nuclear substructures in quiescently infected human fibroblasts. J Virol, 81(20), 10991-1004 (2007)
82. T. H. Shen, H. K. Lin, P. P. Scaglioni, T. M. Yung and P. P. Pandolfi: The mechanisms of PML-nuclear body formation. Mol Cell, 24(3), 331-9 (2006)
83. G. Dellaire, R. Farrall and W. A. Bickmore: The Nuclear Protein Database (NPD): sub-nuclear localisation and functional annotation of the nuclear proteome. Nucleic Acids Res, 31(1), 328-30 (2003)
84. S. Kurki, L. Latonen and M. Laiho: Cellular stress and DNA damage invoke temporally distinct Mdm2, p53 and PML complexes and damage-specific nuclear relocalization. J Cell Sci, 116(Pt 19), 3917-25 (2003)
85. Y. C. Chen, C. Kappel, J. Beaudouin, R. Eils and D. L. Spector: Live cell dynamics of promyelocytic leukemia nuclear bodies upon entry into and exit from mitosis. Mol Biol Cell, 19(7), 3147-62 (2008)
86. A. Kakizuka, W. H. Miller, Jr., K. Umesono, R. P. Warrell, Jr., S. R. Frankel, V. V. Murty, E. Dmitrovsky and R. M. Evans: Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell, 66(4), 663-74 (1991)
87. G. Dellaire and D. P. Bazett-Jones: Beyond repair foci: subnuclear domains and the cellular response to DNA damage. Cell Cycle, 6(15), 1864-72 (2007)
88. H. M. Bøe SO, Jul-Larsen A, Grudic A, Bjerkvig R, Lønning PE: Promyelocytic leukemia nuclear bodies are predetermined processing sites for damaged DNA. J Cell Sci, 119 3284-95 (2006)
89. C. L. Fasching, K. Bower and R. R. Reddel: Telomerase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies. Cancer Res, 65(7), 2722-9 (2005)
90. M. A. Cerone, C. Autexier, J. A. Londono-Vallejo and S. Bacchetti: A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT. Oncogene, 24(53), 7893-901 (2005)
91. R. A. Marciniak, D. Cavazos, R. Montellano, Q. Chen, L. Guarente and F. B. Johnson: A novel telomere structure in a human alternative lengthening of telomeres cell line. Cancer Res, 65(7), 2730-7 (2005)
92. Q. Chen, A. Ijpma and C. W. Greider: Two survivor pathways that allow growth in the absence of telomerase are generated by distinct telomere recombination events. Mol Cell Biol, 21(5), 1819-27 (2001)
93. A. Sfeir, S. T. Kosiyatrakul, D. Hockemeyer, S. L. MacRae, J. Karlseder, C. L. Schildkraut and T. de Lange: Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication. Cell, 138(1), 90-103 (2009)
94. E. L. Denchi and T. de Lange: Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1. Nature, 448(7157), 1068-71 (2007)
95. A. Sfeir, S. Kabir, M. van Overbeek, G. B. Celli and T. de Lange: Loss of Rap1 induces telomere recombination in the absence of NHEJ or a DNA damage signal. Science, 327(5973), 1657-61 (2010)
96. G. B. Celli, E. L. Denchi and T. de Lange: Ku70 stimulates fusion of dysfunctional telomeres yet protects chromosome ends from homologous recombination. Nat Cell Biol, 8(8), 885-90 (2006)
97. W. Palm, D. Hockemeyer, T. Kibe and T. de Lange: Functional dissection of human and mouse POT1 proteins. Mol Cell Biol, 29(2), 471-82 (2009)
98. J. Dejardin and R. E. Kingston: Purification of proteins associated with specific genomic Loci. Cell, 136(1), 175-86 (2009)
99. W. Q. Jiang, Z. H. Zhong, J. D. Henson and R. R. Reddel: Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference. Oncogene, 26(32), 4635-47 (2007)
100. P. R. Potts and H. Yu: The SMC5/6 complex maintains telomere length in ALT cancer cells through SUMOylation of telomere-binding proteins. Nat Struct Mol Biol, 14(7), 581-90 (2007)
101. A. J. van Brabant, T. Ye, M. Sanz, I. J. German, N. A. Ellis and W. K. Holloman: Binding and melting of D-loops by the Bloom syndrome helicase. Biochemistry, 39(47), 14617-25 (2000)
102. D. J. Stavropoulos, P. S. Bradshaw, X. Li, I. Pasic, K. Truong, M. Ikura, M. Ungrin and M. S. Meyn: The Bloom syndrome helicase BLM interacts with TRF2 in ALT cells and promotes telomeric DNA synthesis. Hum Mol Genet, 11(25), 3135-44 (2002)
103. K. Lillard-Wetherell, A. Machwe, G. T. Langland, K. A. Combs, G. K. Behbehani, S. A. Schonberg, J. German, J. J. Turchi, D. K. Orren and J. Groden: Association and regulation of the BLM helicase by the telomere proteins TRF1 and TRF2. Hum Mol Genet, 13(17), 1919-32 (2004)
104. S. Zhong, P. Hu, T. Z. Ye, R. Stan, N. A. Ellis and P. P. Pandolfi: A role for PML and the nuclear body in genomic stability. Oncogene, 18(56), 7941-7 (1999)
105. C. Y. Lu, C. H. Tsai, S. J. Brill and S. C. Teng: Sumoylation of the BLM ortholog, Sgs1, promotes telomere-telomere recombination in budding yeast. Nucleic Acids Res, 38(2), 488-98 (2010)
106. S. Eladad, T. Z. Ye, P. Hu, M. Leversha, S. Beresten, M. J. Matunis and N. A. Ellis: Intra-nuclear trafficking of the BLM helicase to DNA damage-induced foci is regulated by SUMO modification. Hum Mol Genet, 14(10), 1351-65 (2005)
107. L. Crabbe, R. E. Verdun, C. I. Haggblom and J. Karlseder: Defective telomere lagging strand synthesis in cells lacking WRN helicase activity. Science, 306(5703), 1951-3 (2004)
108. P. R. Laud, A. S. Multani, S. M. Bailey, L. Wu, J. Ma, C. Kingsley, M. Lebel, S. Pathak, R. A. DePinho and S. Chang: Elevated telomere-telomere recombination in WRN-deficient, telomere dysfunctional cells promotes escape from senescence and engagement of the ALT pathway. Genes Dev, 19(21), 2560-70 (2005)
109. P. L. Opresko, M. Otterlei, J. Graakjaer, P. Bruheim, L. Dawut, S. Kolvraa, A. May, M. M. Seidman and V. A. Bohr: The Werner syndrome helicase and exonuclease cooperate to resolve telomeric D loops in a manner regulated by TRF1 and TRF2. Mol Cell, 14(6), 763-74 (2004)
110. H. Ding, M. Schertzer, X. Wu, M. Gertsenstein, S. Selig, M. Kammori, R. Pourvali, S. Poon, I. Vulto, E. Chavez, P. P. Tam, A. Nagy and P. M. Lansdorp: Regulation of murine telomere length by Rtel: an essential gene encoding a helicase-like protein. Cell, 117(7), 873-86 (2004)
111. C. M. Azzalin, P. Reichenbach, L. Khoriauli, E. Giulotto and J. Lingner: Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends. Science, 318(5851), 798-801 (2007)
112. S. Schoeftner and M. A. Blasco: Developmentally regulated transcription of mammalian telomeres by DNA-dependent RNA polymerase II. Nat Cell Biol, 10(2), 228-36 (2008)
113. S. G. Nergadze, B. O. Farnung, H. Wischnewski, L. Khoriauli, V. Vitelli, R. Chawla, E. Giulotto and C. M. Azzalin: CpG-island promoters drive transcription of human telomeres. Rna, 15(12), 2186-94 (2009)
114. S. Gonzalo, I. Jaco, M. F. Fraga, T. Chen, E. Li, M. Esteller and M. A. Blasco: DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nat Cell Biol, 8(4), 416-24 (2006)
115. R. Benetti, S. Gonzalo, I. Jaco, P. Munoz, S. Gonzalez, S. Schoeftner, E. Murchison, T. Andl, T. Chen, P. Klatt, E. Li, M. Serrano, S. Millar, G. Hannon and M. A. Blasco: A mammalian microRNA cluster controls DNA methylation and telomere recombination via Rbl2-dependent regulation of DNA methyltransferases. Nat Struct Mol Biol, 15(9), 998 (2008)
116. S. Yehezkel, Y. Segev, E. Viegas-Pequignot, K. Skorecki and S. Selig: Hypomethylation of subtelomeric regions in ICF syndrome is associated with abnormally short telomeres and enhanced transcription from telomeric regions. Hum Mol Genet, 17(18), 2776-89 (2008)
117. Z. H. Xie, Y. N. Huang, Z. X. Chen, A. D. Riggs, J. P. Ding, H. Gowher, A. Jeltsch, H. Sasaki, K. Hata and G. L. Xu: Mutations in DNA methyltransferase DNMT3B in ICF syndrome affect its regulation by DNMT3L. Hum Mol Genet, 15(9), 1375-85 (2006)
118. O. El-Maarri, M. S. Kareta, T. Mikeska, T. Becker, A. Diaz-Lacava, J. Junen, N. Nusgen, F. Behne, T. Wienker, A. Waha, J. Oldenburg and F. Chedin: A systematic search for DNA methyltransferase polymorphisms reveals a rare DNMT3L variant associated with subtelomeric hypomethylation. Hum Mol Genet, 18(10), 1755-68 (2009)
119. L. J. Ng, J. E. Cropley, H. A. Pickett, R. R. Reddel and C. M. Suter: Telomerase activity is associated with an increase in DNA methylation at the proximal subtelomere and a reduction in telomeric transcription. Nucleic Acids Res, 37(4), 1152-9 (2009)
120. G. Tilman, A. Loriot, A. Van Beneden, N. Arnoult, J. A. Londono-Vallejo, C. De Smet and A. Decottignies: Subtelomeric DNA hypomethylation is not required for telomeric sister chromatid exchanges in ALT cells. Oncogene, 28(14), 1682-93 (2009)
121. R. Benetti, S. Gonzalo, I. Jaco, G. Schotta, P. Klatt, T. Jenuwein and M. A. Blasco: Suv4-20h deficiency results in telomere elongation and derepression of telomere recombination. J Cell Biol, 178(6), 925-36 (2007)
122. R. J. O'Sullivan, S. Kubicek, S. L. Schreiber and J. Karlseder: Reduced histone biosynthesis and chromatin changes arising from a damage signal at telomeres. Nat Struct Mol Biol, 17(10), 1218-25 (2010)
123. S. B. Hake and C. D. Allis: Histone H3 variants and their potential role in indexing mammalian genomes: the "H3 barcode hypothesis". Proc Natl Acad Sci U S A, 103(17), 6428-35 (2006)
124. A. D. Goldberg, L. A. Banaszynski, K. M. Noh, P. W. Lewis, S. J. Elsaesser, S. Stadler, S. Dewell, M. Law, X. Guo, X. Li, D. Wen, A. Chapgier, R. C. DeKelver, J. C. Miller, Y. L. Lee, E. A. Boydston, M. C. Holmes, P. D. Gregory, J. M. Greally, S. Rafii, C. Yang, P. J. Scambler, D. Garrick, R. J. Gibbons, D. R. Higgs, I. M. Cristea, F. D. Urnov, D. Zheng and C. D. Allis: Distinct factors control histone variant H3.3 localization at specific genomic regions. Cell, 140(5), 678-91 (2010)
125. M. J. Law, K. M. Lower, H. P. Voon, J. R. Hughes, D. Garrick, V. Viprakasit, M. Mitson, M. De Gobbi, M. Marra, A. Morris, A. Abbott, S. P. Wilder, S. Taylor, G. M. Santos, J. Cross, H. Ayyub, S. Jones, J. Ragoussis, D. Rhodes, I. Dunham, D. R. Higgs and R. J. Gibbons: ATR-X syndrome protein targets tandem repeats and influences allele-specific expression in a size-dependent manner. Cell, 143(3), 367-78 (2010)
126. E. Szenker, D. Ray-Gallet and G. Almouzni: The double face of the histone variant H3.3. Cell Res, 21(3), 421-34 (2011)
127. J. Tang, S. Wu, H. Liu, R. Stratt, O. G. Barak, R. Shiekhattar, D. J. Picketts and X. Yang: A novel transcription regulatory complex containing death domain-associated protein and the ATR-X syndrome protein. J Biol Chem, 279(19), 20369-77 (2004)
128. X. Nan, J. Hou, A. Maclean, J. Nasir, M. J. Lafuente, X. Shu, S. Kriaucionis and A. Bird: Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardation. Proc Natl Acad Sci U S A, 104(8), 2709-14 (2007)
129. C. M. Heaphy, R. F. de Wilde, Y. Jiao, A. P. Klein, B. H. Edil, C. Shi, C. Bettegowda, F. J. Rodriguez, C. G. Eberhart, S. Hebbar, J. A. Offerhaus, R. McLendon, B. A. Rasheed, Y. He, H. Yan, D. D. Bigner, S. M. Oba-Shinjo, S. K. Marie, G. J. Riggins, K. W. Kinzler, B. Vogelstein, R. H. Hruban, A. Maitra, N. Papadopoulos and A. K. Meeker: Altered Telomeres in Tumors with ATRX and DAXX Mutations. Science (2011)
130. P. Kaminker, C. Plachot, S. H. Kim, P. Chung, D. Crippen, O. W. Petersen, M. J. Bissell, J. Campisi and S. A. Lelievre: Higher-order nuclear organization in growth arrest of human mammary epithelial cells: a novel role for telomere-associated protein TIN2. J Cell Sci, 118(Pt 6), 1321-30 (2005)
131. C. Netzer, S. K. Bohlander, L. Rieger, S. Muller and J. Kohlhase: Interaction of the developmental regulator SALL1 with UBE2I and SUMO-1. Biochem Biophys Res Commun, 296(4), 870-6 (2002)
132. W. Q. Jiang, Z. H. Zhong, A. Nguyen, J. D. Henson, C. D. Toouli, A. W. Braithwaite and R. R. Reddel: Induction of alternative lengthening of telomeres-associated PML bodies by p53/p21 requires HP1 proteins. J Cell Biol, 185(5), 797-810 (2009)
133. W. Q. Jiang, A. Nguyen, Y. Cao, A. C. Chang and R. R. Reddel: HP1-mediated formation of alternative lengthening of telomeres-associated PML bodies requires HIRA but not ASF1a. PLoS One, 6(2), e17036 (2011)
134. S. Yehezkel, A. Rebibo-Sabbah, Y. Segev, M. Tzukerman, R. Shaked, I. Huber, L. Gepstein, K. Skorecki and S. Selig: Reprogramming of telomeric regions during the generation of human induced pluripotent stem cells and subsequent differentiation into fibroblast-like derivatives. Epigenetics, 6(1), 63-75 (2011)
135. A. Porro, S. Feuerhahn, P. Reichenbach and J. Lingner: Molecular dissection of telomeric repeat-containing RNA biogenesis unveils the presence of distinct and multiple regulatory pathways. Mol Cell Biol, 30(20), 4808-17 (2010)
136. R. Benetti, M. Garcia-Cao and M. A. Blasco: Telomere length regulates the epigenetic status of mammalian telomeres and subtelomeres. Nat Genet, 39(2), 243-50 (2007)
137. M. Lang, T. Jegou, I. Chung, K. Richter, S. Munch, A. Udvarhelyi, C. Cremer, P. Hemmerich, J. Engelhardt, S. W. Hell and K. Rippe: Three-dimensional organization of promyelocytic leukemia nuclear bodies. J Cell Sci, 123(Pt 3), 392-400 (2010)